Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 QOL Medical Approved for Sacrosidase Manufacture | Contract Pharma

What are you searching for?

Sign in

QOL Medical Approved for Sacrosidase Manufacture

FDA approved wholly owned manufacturing facility in Clearwater, Florida to manufacture substance used to make Sucraid®

By: Betsy Louda

, Contract Pharma

QOL Medical, LLC announced that the U.S. Food and Drug Administration has approved the company’s wholly owned manufacturing facility in Clearwater, Florida to manufacture sacrosidase, the drug substance used to make Sucraid® (sacrosidase) Oral Solution.  

The Sucraid® drug shortage has been resolved, and this FDA approval eliminates the need for informed consents, assents, physician acknowledgments, and patient questionnaires for all Sucraid® prescriptions. Sucraid® is now available as a regular prescription exclusively from US Bioservices. 


The long-term supply of Sucraid® continues to be QOL Medical’s top priority. QOL Medical has developed an improved manufacturing process for sacrosidase production, designed and built a wholly owned cGMP-compliant manufacturing facility, and hired an experienced manufacturing and quality team to assure this goal. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics